ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $334,004 | +12.1% | 15,456 | +0.5% | 0.00% | 0.0% |
| Q3 2022 | $298,000 | -60.3% | 15,381 | -59.3% | 0.00% | -66.7% |
| Q2 2022 | $751,000 | -54.9% | 37,836 | -32.3% | 0.00% | -50.0% |
| Q1 2022 | $1,667,000 | -1.7% | 55,871 | -23.3% | 0.01% | +20.0% |
| Q4 2021 | $1,696,000 | -35.0% | 72,838 | -12.9% | 0.01% | -44.4% |
| Q3 2021 | $2,609,000 | +22.5% | 83,613 | +38.1% | 0.01% | +28.6% |
| Q2 2021 | $2,130,000 | +1.7% | 60,542 | +1.9% | 0.01% | -12.5% |
| Q1 2021 | $2,095,000 | +3.7% | 59,425 | +10.3% | 0.01% | +14.3% |
| Q4 2020 | $2,021,000 | +26.6% | 53,873 | +12.7% | 0.01% | 0.0% |
| Q3 2020 | $1,596,000 | +63.5% | 47,814 | +29.8% | 0.01% | +40.0% |
| Q2 2020 | $976,000 | +47.4% | 36,844 | -8.9% | 0.01% | +25.0% |
| Q1 2020 | $662,000 | -33.4% | 40,426 | +3.4% | 0.00% | -20.0% |
| Q4 2019 | $994,000 | +6.0% | 39,088 | -16.7% | 0.01% | 0.0% |
| Q3 2019 | $938,000 | -39.5% | 46,915 | -2.5% | 0.01% | -44.4% |
| Q2 2019 | $1,551,000 | +65.0% | 48,110 | +64.8% | 0.01% | +50.0% |
| Q1 2019 | $940,000 | +39.3% | 29,199 | +6.1% | 0.01% | +20.0% |
| Q4 2018 | $675,000 | – | 27,522 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |